ZUCALI, PAOLO ANDREA
ZUCALI, PAOLO ANDREA
Dipartimento Scienze Biomediche
"One marker does not fit all": additional translational and validation studies are needed to identify faithful predictors of pemetrexed activity in mesothelioma
2013-01-01 Giovannetti, Elisa; Peters, Godefridus J; Zucali, Paolo A
2-¹⁸fluoro-deoxy-D-glucose positron emission tomography (FDG-PET) for postchemotherapy seminoma residual lesions: a retrospective validation of the SEMPET trial
2012-01-01 Bachner, M; Loriot, Y; Gross-Goupil, M; Zucali, P A; Horwich, A; Germa-Lluch, J-R; Kollmannsberger, C; Stoiber, F; Fléchon, A; Oechsle, K; Gillessen, S; Oldenburg, J; Cohn-Cedermark, G; Daugaard, G; Morelli, F; Sella, A; Harland, S; Kerst, M; Gampe, J; Dittrich, C; Fizazi, K; De Santis, M
721P Ipilimumab and nivolumab compassionate use program in metastatic renal cell carcinoma patients with intermediate or poor IMDC risk score: The large multicenter Italian study
2020-01-01 Basso, U.; Paolieri, F.; Porta, C. G.; De Giorgi, U.; Bracarda, S.; Antonuzzo, L.; Atzori, F.; Cartenì, G.; Procopio, G.; Fratino, L.; D'Arcangelo, M.; Fornarini, G.; Zucali, P. A.; Cusmai, A.; Santoni, M.; Baldessari, C.; Naglieri, E.; Panni, S.; Zagonel, V.; Tortora, G.
[Combination of 5-Fluorouracil and folinic acid--is it still the standard therapy for advanced colorectal carcinoma?]
2000-01-01 Carnaghi, C; Zucali, P; Garassino, I
A phase 1 dose-escalation study of the oral histone deacetylase inhibitor abexinostat in combination with standard hypofractionated radiotherapy in advanced solid tumors
2017-01-01 Deutsch, Eric; Moyal, Elizabeth Cohen-Jonathan; Gregorc, Vanesa; Zucali, Paolo Andrea; Menard, Jean; Soria, Jean-Charles; Kloos, Ioana; Hsu, Jeff; Luan, Ying; Liu, Emily; Vezan, Remus; Graef, Thorsten; Rivera, Sofia
A phase II study of the combination of gemcitabine and imatinib mesylate in pemetrexed-pretreated patients with malignant pleural mesothelioma
2020-01-01 Zucali, Pa; Perrino, M; de Vincenzo, F; Giordano, L; Cordua, N; D’Antonio, F; Santoro, A
A Phase-1b study of tivantinib (ARQ 197) in adult patients with hepatocellular carcinoma and cirrhosis
2013-01-01 Santoro, A; Simonelli, M; Rodriguez-Lope, C; Zucali, P; Camacho, Lh; Granito, A; Senzer, N; Rimassa, L; Abbadessa, G; Schwartz, B; Lamar, M; Savage, Re; Bruix, J
A red blood cell-based score in the prognostication of patients with metastatic RCC of the Meet-URO 15 study
2024-01-01 Anpalakhan, Shobana; Banna, Giuseppe Luigi; Rebuzzi, Sara Elena; Fornarini, Giuseppe; Maruzzo, Marco; Zucali, Paolo Andrea; Catalano, Fabio; Antonj, Ludovica; Tudini, Marianna; Fratino, Lucia; Malgeri, Andrea; Rescigno, Pasquale; Signori, Alessio; Acunzo, Alessandro; Silini, Enrico Maria; Mazzaschi, Giulia; Buti, Sebastiano
A specific inhibitor of lactate dehydrogenase overcame the resistance toward gemcitabine in hypoxic mesothelioma cells, and modulated the expression of the human equilibrative transporter-1
2016-01-01 Giovannetti, Elisa; Leon, Leticia G; Gómez, Valentina E; Zucali, Paolo A; Minutolo, Filippo; Peters, Godefridus J
A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors
2014-01-01 Petrini, Iacopo; Meltzer, Paul S; Kim, In-Kyu; Lucchi, Marco; Park, Kang-Seo; Fontanini, Gabriella; Gao, James; Zucali, Paolo A; Calabrese, Fiorella; Favaretto, Adolfo; Rea, Federico; Rodriguez-Canales, Jaime; Walker, Robert L; Pineda, Marbin; Zhu, Yuelin J; Lau, Christopher; Killian, Keith J; Bilke, Sven; Voeller, Donna; Dakshanamurthy, Sivanesan; Wang, Yisong; Giaccone, Giuseppe
Achieving Consensus for Management of Hormone-Sensitive, Low-Volume Metastatic Prostate Cancer in Italy
2022-01-01 Verzoni, Elena; Pappagallo, Giovanni; Alongi, Filippo; Arcangeli, Stefano; Francolini, Giulio; Galanti, Daniele; Galli, Luca; Maruzzo, Marco; Rossetti, Sabrina; Siepe, Giambattista; Triggiani, Luca; Zucali, Paolo Andrea; D'Angelillo, Rolando Maria
Activity and safety of trabectedin in patients with sarcomatoid / biphasic malignant pleural mesothelioma (MPM)
2015-01-01 Cortinovis, Dl; Hollander, Lh; Floriani, Ic; Grosso, F; Marinello, A; Ceresoli, Gl; Pacchetti, I; Zucali, Pa; D'Incalci, M; Canova, S; Abbate, Mi; Ugo, F; Vukcaj, S; Bidoli, P
Activity of a specific inhibitor, gefitinib (Iressa, ZD1839), of epidermal growth factor receptor in refractory non-small-cell lung cancer
2004-01-01 Santoro, A.; Cavina, R.; Latteri, F.; Zucali, P. A.; Ginanni, V.; Campagnoli, E.; Ferrari, B.; Morenghi, E.; Pedicini, V.; Roncalli, M.; Alloisio, M.; Ravasi, G.; Soto Parra, H. J.
Addition of temozolomide to radiotherapy for treatment of newly diagnosed anaplastic gliomas
2009-01-01 Simonelli, M; Banna, G; Navarria, P; Di Ieva, A; Zucali, P; De Vincenzo, F; Gaetani, P; Condorelli, R; Baena, Rry; Scorsetti, M; Santoro, A
Advances in drug treatments for mesothelioma
2022-01-01 Zucali, Paolo Andrea; De Vincenzo, Fabio; Perrino, Matteo; Digiacomo, Nunzio; Cordua, Nadia; D'Antonio, Federica; Borea, Federica; Fazio, Roberta; Pirozzi, Angelo; Santoro, Armando
Advances in the biology of malignant pleural mesothelioma
2011-01-01 Zucali, Pa; Ceresoli, Gl; De Vincenzo, F; Simonelli, M; Lorenzi, E; Gianoncelli, L; Santoro, A
An Italian survey on the use of denosumab for the management of skeletal-related events in patients with bone metastases
2022-01-01 Berardi, R; Berruti, A; Brogelli, L; Zucali, P A
Analysis of epidermal growth factor receptor expression as a predictive factor for response to gefitinib ('Iressa', ZD1839) in non-small-cell lung cancer
2004-01-01 Parra, Hs; Cavina, R; Latteri, F; Zucali, Pa; Campagnoli, E; Morenghi, E; Grimaldi, Gc; Roncalli, M; Santoro, A
Anti-angiogenic therapies for malignant pleural mesothelioma
2012-01-01 Ceresoli, Giovanni Luca; Zucali, Paolo Andrea
Antiproliferative effects of novel aliphatic acetogenin analogs against aggressive solid tumor cell lines
2011-01-01 León, Leticia G; Giovannetti, Elisa; Alecci, Claudia; Giancola, Fiorella; Funel, Niccola; Zucali, Paolo; Peters, Godefridus J; Padrón, José M
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| "One marker does not fit all": additional translational and validation studies are needed to identify faithful predictors of pemetrexed activity in mesothelioma | 1-gen-2013 | Giovannetti, Elisa; Peters, Godefridus J; Zucali, Paolo A | |
| 2-¹⁸fluoro-deoxy-D-glucose positron emission tomography (FDG-PET) for postchemotherapy seminoma residual lesions: a retrospective validation of the SEMPET trial | 1-gen-2012 | Bachner, M; Loriot, Y; Gross-Goupil, M; Zucali, P A; Horwich, A; Germa-Lluch, J-R; Kollmannsberger, C; Stoiber, F; Fléchon, A; Oechsle, K; Gillessen, S; Oldenburg, J; Cohn-Cedermark, G; Daugaard, G; Morelli, F; Sella, A; Harland, S; Kerst, M; Gampe, J; Dittrich, C; Fizazi, K; De Santis, M | |
| 721P Ipilimumab and nivolumab compassionate use program in metastatic renal cell carcinoma patients with intermediate or poor IMDC risk score: The large multicenter Italian study | 1-gen-2020 | Basso, U.; Paolieri, F.; Porta, C. G.; De Giorgi, U.; Bracarda, S.; Antonuzzo, L.; Atzori, F.; Cartenì, G.; Procopio, G.; Fratino, L.; D'Arcangelo, M.; Fornarini, G.; Zucali, P. A.; Cusmai, A.; Santoni, M.; Baldessari, C.; Naglieri, E.; Panni, S.; Zagonel, V.; Tortora, G. | |
| [Combination of 5-Fluorouracil and folinic acid--is it still the standard therapy for advanced colorectal carcinoma?] | 1-gen-2000 | Carnaghi, C; Zucali, P; Garassino, I | |
| A phase 1 dose-escalation study of the oral histone deacetylase inhibitor abexinostat in combination with standard hypofractionated radiotherapy in advanced solid tumors | 1-gen-2017 | Deutsch, Eric; Moyal, Elizabeth Cohen-Jonathan; Gregorc, Vanesa; Zucali, Paolo Andrea; Menard, Jean; Soria, Jean-Charles; Kloos, Ioana; Hsu, Jeff; Luan, Ying; Liu, Emily; Vezan, Remus; Graef, Thorsten; Rivera, Sofia | |
| A phase II study of the combination of gemcitabine and imatinib mesylate in pemetrexed-pretreated patients with malignant pleural mesothelioma | 1-gen-2020 | Zucali, Pa; Perrino, M; de Vincenzo, F; Giordano, L; Cordua, N; D’Antonio, F; Santoro, A | |
| A Phase-1b study of tivantinib (ARQ 197) in adult patients with hepatocellular carcinoma and cirrhosis | 1-gen-2013 | Santoro, A; Simonelli, M; Rodriguez-Lope, C; Zucali, P; Camacho, Lh; Granito, A; Senzer, N; Rimassa, L; Abbadessa, G; Schwartz, B; Lamar, M; Savage, Re; Bruix, J | |
| A red blood cell-based score in the prognostication of patients with metastatic RCC of the Meet-URO 15 study | 1-gen-2024 | Anpalakhan, Shobana; Banna, Giuseppe Luigi; Rebuzzi, Sara Elena; Fornarini, Giuseppe; Maruzzo, Marco; Zucali, Paolo Andrea; Catalano, Fabio; Antonj, Ludovica; Tudini, Marianna; Fratino, Lucia; Malgeri, Andrea; Rescigno, Pasquale; Signori, Alessio; Acunzo, Alessandro; Silini, Enrico Maria; Mazzaschi, Giulia; Buti, Sebastiano | |
| A specific inhibitor of lactate dehydrogenase overcame the resistance toward gemcitabine in hypoxic mesothelioma cells, and modulated the expression of the human equilibrative transporter-1 | 1-gen-2016 | Giovannetti, Elisa; Leon, Leticia G; Gómez, Valentina E; Zucali, Paolo A; Minutolo, Filippo; Peters, Godefridus J | |
| A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors | 1-gen-2014 | Petrini, Iacopo; Meltzer, Paul S; Kim, In-Kyu; Lucchi, Marco; Park, Kang-Seo; Fontanini, Gabriella; Gao, James; Zucali, Paolo A; Calabrese, Fiorella; Favaretto, Adolfo; Rea, Federico; Rodriguez-Canales, Jaime; Walker, Robert L; Pineda, Marbin; Zhu, Yuelin J; Lau, Christopher; Killian, Keith J; Bilke, Sven; Voeller, Donna; Dakshanamurthy, Sivanesan; Wang, Yisong; Giaccone, Giuseppe | |
| Achieving Consensus for Management of Hormone-Sensitive, Low-Volume Metastatic Prostate Cancer in Italy | 1-gen-2022 | Verzoni, Elena; Pappagallo, Giovanni; Alongi, Filippo; Arcangeli, Stefano; Francolini, Giulio; Galanti, Daniele; Galli, Luca; Maruzzo, Marco; Rossetti, Sabrina; Siepe, Giambattista; Triggiani, Luca; Zucali, Paolo Andrea; D'Angelillo, Rolando Maria | |
| Activity and safety of trabectedin in patients with sarcomatoid / biphasic malignant pleural mesothelioma (MPM) | 1-gen-2015 | Cortinovis, Dl; Hollander, Lh; Floriani, Ic; Grosso, F; Marinello, A; Ceresoli, Gl; Pacchetti, I; Zucali, Pa; D'Incalci, M; Canova, S; Abbate, Mi; Ugo, F; Vukcaj, S; Bidoli, P | |
| Activity of a specific inhibitor, gefitinib (Iressa, ZD1839), of epidermal growth factor receptor in refractory non-small-cell lung cancer | 1-gen-2004 | Santoro, A.; Cavina, R.; Latteri, F.; Zucali, P. A.; Ginanni, V.; Campagnoli, E.; Ferrari, B.; Morenghi, E.; Pedicini, V.; Roncalli, M.; Alloisio, M.; Ravasi, G.; Soto Parra, H. J. | |
| Addition of temozolomide to radiotherapy for treatment of newly diagnosed anaplastic gliomas | 1-gen-2009 | Simonelli, M; Banna, G; Navarria, P; Di Ieva, A; Zucali, P; De Vincenzo, F; Gaetani, P; Condorelli, R; Baena, Rry; Scorsetti, M; Santoro, A | |
| Advances in drug treatments for mesothelioma | 1-gen-2022 | Zucali, Paolo Andrea; De Vincenzo, Fabio; Perrino, Matteo; Digiacomo, Nunzio; Cordua, Nadia; D'Antonio, Federica; Borea, Federica; Fazio, Roberta; Pirozzi, Angelo; Santoro, Armando | |
| Advances in the biology of malignant pleural mesothelioma | 1-gen-2011 | Zucali, Pa; Ceresoli, Gl; De Vincenzo, F; Simonelli, M; Lorenzi, E; Gianoncelli, L; Santoro, A | |
| An Italian survey on the use of denosumab for the management of skeletal-related events in patients with bone metastases | 1-gen-2022 | Berardi, R; Berruti, A; Brogelli, L; Zucali, P A | |
| Analysis of epidermal growth factor receptor expression as a predictive factor for response to gefitinib ('Iressa', ZD1839) in non-small-cell lung cancer | 1-gen-2004 | Parra, Hs; Cavina, R; Latteri, F; Zucali, Pa; Campagnoli, E; Morenghi, E; Grimaldi, Gc; Roncalli, M; Santoro, A | |
| Anti-angiogenic therapies for malignant pleural mesothelioma | 1-gen-2012 | Ceresoli, Giovanni Luca; Zucali, Paolo Andrea | |
| Antiproliferative effects of novel aliphatic acetogenin analogs against aggressive solid tumor cell lines | 1-gen-2011 | León, Leticia G; Giovannetti, Elisa; Alecci, Claudia; Giancola, Fiorella; Funel, Niccola; Zucali, Paolo; Peters, Godefridus J; Padrón, José M |